A cosa serve il resveratrolo? Proprietà e benefici

resveratrol para que sirve


resveratrol propiedades

KOCORO

Con Veri-te™, trans-resveratrolo ad alta purezza (>98%), libero da contaminanti e capace di attraversare la barriera ematoencefalica

resveratrol beneficios
Per usi clinici, Veri-te™ è una delle forme più sicure, pure ed efficaci sul mercato.
Bibliografía
  • Beaudeux, J., Nivet-Antoine, V., & Giral, P. “Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome?” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 13, no. 6, 2010, pp. 729–736.
  • Bitterman, J. L., & Chung, J. H. “Metabolic effects of resveratrol: addressing the controversies.” Cellular and Molecular Life Sciences, vol. 71, 2014, pp. 2191–2198.
  • Bremer, Alexander. «Resveratrol use in metabolic syndrome.» Metabolic Syndrome and Related Disorders, vol. 12, no. 3, 2014, pp. 143–147. https://doi.org/10.1089/met.2013.0114
  • Brown, K., et al. “Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities.” International Journal of Molecular Sciences, vol. 25, no. 2, 2024, article 747. https://doi.org/10.3390/ijms25020747
  • Carrizzo, A., et al. “Resveratrol Improves Vascular Function in Patients With Hypertension and Dyslipidemia by Modulating NO Metabolism.” Hypertension, vol. 62, no. 2, 2013, pp. 359–366.
  • Carrizzo, A., et al. “Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases.” Food and Chemical Toxicology, vol. 61, 2013, pp. 215–226.
  • Damay, Vito A, and Ignatius Ivan. “Resveratrol as an Anti-inflammatory Agent in Coronary Artery Disease: A Systematic Review, Meta-Analysis and Meta-Regression.” Chinese journal of integrative medicine vol. 30,10 (2024): 927-937. doi:10.1007/s11655-024-3665-0
  • Delpino, Felipe Mendes, and Lílian Munhoz Figueiredo. “Resveratrol supplementation and type 2 diabetes: a systematic review and meta-analysis.” Critical reviews in food science and nutrition vol. 62,16 (2022): 4465-4480. doi:10.1080/10408398.2021.1875980
  • Gaggini, M., Fenizia, S., & Vassalle, C. “Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease.” Antioxidants, vol. 12, no. 3, 2023, p. 594.
  • Gál, R., et al. “Resveratrol and beyond: The Effect of Natural Polyphenols on the Cardiovascular System: A Narrative Review.” Biomedicines, vol. 11, no. 11, 2023, article 2888. https://doi.org/10.3390/biomedicines11112888
  • Guerrero, R. F., et al. “Resveratrol and wine: A review of recent evidence and emerging biomedical applications.” Critical Reviews in Food Science and Nutrition, vol. 60, no. 17, 2020, pp. 2890–2906.
  • Kulkarni, S. S., et al. “Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α.” Cell Metabolism, vol. 12, no. 6, 2010, pp. 662–667.
  • Liu, Xiaojing et al. “Resveratrol delays the progression of diabetic nephropathy through multiple pathways: A dose-response meta-analysis based on animal models.” Journal of diabetes vol. 16,9 (2024): e13608. doi:10.1111/1753-0407.13608
  • Markhon, N., et al. “Effect of Resveratrol on Metabolic Syndrome.” Ukraïnsʹkij žurnal medicini bìologìï ta sportu, vol. 6, no. 3, 2021.
  • Mohammadipoor, Nazanin et al. “Resveratrol supplementation efficiently improves endothelial health: A systematic review and meta-analysis of randomized controlled trials.” Phytotherapy research : PTR vol. 36,9 (2022): 3529-3539. doi:10.1002/ptr.7562
  • Olas, B. “Health benefits of resveratrol in aging and age-related disorders.” Ageing Research Reviews, vol. 62, 2020, p. 101051.
  • Pallàs, M., et al. “Resveratrol, a polyphenol in wine: Resveratrol targets in neurodegenerative diseases.” Nutritional Neuroscience, vol. 22, no. 7, 2019, pp. 469–478.
  • Patel, K. R., et al. “Clinical trials of resveratrol.” Annals of the New York Academy of Sciences, vol. 1215, no. 1, 2011, pp. 161–169.
  • Poulsen, M. M., et al. “High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.” Diabetes, vol. 62, no. 4, 2013, pp. 1186–1195.
  • Sergi, C., et al. “Usefulness of resveratrol supplementation in decreasing cardiometabolic risk factors comparing subjects with metabolic syndrome and healthy subjects with or without obesity: meta-analysis using multinational, randomized, controlled trials.” Archives of Medical Science, vol. 16, no. 1, 2020, pp. 183–195.
  • Smoliga, J. M., et al. “Resveratrol: Transcending the French paradox.” Journal of Physiology, vol. 591, no. 20, 2013, pp. 5073–5085.
  • Timmers, S., et al. “Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.” Cell Metabolism, vol. 14, no. 5, 2011, pp. 612–622.
  • Tomé-Carneiro, J., et al. “Resveratrol supplementation in patients undergoing primary prevention of cardiovascular disease: a pilot study.” Nutrition, vol. 29, no. 1, 2013, pp. 178–183.
  • Wang, S., et al. “Resveratrol inhibits malignant properties of cutaneous melanoma cells through induction of apoptosis and suppression of angiogenesis.” Cancer Letters, vol. 357, no. 1, 2015, pp. 135–143.
  • Wang, Y., et al. “Resveratrol supplementation improves endothelial function in patients with metabolic syndrome: results from a randomized, double-blind, placebo-controlled crossover study.” The American Journal of Clinical Nutrition, vol. 99, no. 1, 2014, pp. 20–29.
  • Wightman, E. L., et al. “Effects of resveratrol on cerebrovascular function in healthy adults.” The Journal of Physiology, vol. 592, no. 16, 2014, pp. 3653–3662.

«`

«`